RxDoctor Payments Data

Karolina Ruthner, APRN

Family · Covington, LANPI 1205486644

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,405 of the $16,907 with a category attached, or 73.4%. 20 manufacturers reported payments, led by Medtronic at 44.6% of the total. Reporting peaked in 2023 at $6,694 and has fallen 70.9% since, to $1,951 in 2025. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,907in general payments, 2019–2025

Across 351 payments — averaging $48.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Edwards Lifesciences$6K
  • Boston Scientific$726
  • AstraZeneca$520
  • Impulse Dynamics (USA) Inc.$462
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$390
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$3002%
  • Travel & lodging$4,20225%
  • Food & beverage$12,40573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,907 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,699
Medicare patients
115
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$12,351
Mupirocin152$1,063
Valsartan25$774
Metoprolol Succinate43$605
Chlorhexidine Gluconate151$595
ClopidogrelClopidogrel Bisulfate64$594
Amiodarone Hcl16$414
Carvedilol35$289
Torsemide21$277
Potassium Chloride15$248
Pantoprazole Sodium21$244
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$221
Amoxicillin78$211
Amlodipine Besylate27$186
Lisinopril12$61

Paid to pharmacies, not to this prescriber.

Other family in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →